Foundayo Is Here – Everything Arizona Patients Need to Know About the New Weight Loss Pill Foundayo

The Big Announcement - Foundayo Weight Loss Pill

On April 1, 2026, Eli Lilly announced that the FDA officially approved Foundayo® (orforglipron), a once-daily oral GLP-1 pill for chronic weight management — and it comes with a game-changing advantage no other weight loss pill has: you can take it any time of day, with no food or water restrictions.

At Phoenix NP, we have been closely following orforglipron's clinical development and are excited to offer this new option to our Arizona patients. As of April 9, 2026, Eli Lilly has made the new weight loss pill, Foundayo, available through their Lilly Direct program, in which Phoenix NP partners with for associated patient prescriptions so our patients receive authentic, FDA-approved weight loss medications direct from the manufacturer. Whether you've been hesitant to try injectable medications, want a more flexible daily routine, or are simply exploring all of your FDA-approved options, Foundayo® may be worth learning about. Here is everything you need to know.

What Is Foundayo® (Orforglipron)?

Foundayo® is Eli Lilly's brand-new once-daily oral GLP-1 receptor agonist — the same company behind the popular injectable weight loss medication Zepbound®. However, Foundayo® is an entirely different and novel medication. While Zepbound® uses tirzepatide (a peptide that must be injected), Foundayo® uses orforglipron, a small molecule compound — meaning it is not a peptide at all.

This distinction is important. Because orforglipron is a small molecule rather than a peptide, the body can absorb it efficiently through the digestive system without the rigid timing requirements of other oral GLP-1 medications. That is the science behind Foundayo's® biggest headline: no food or water restrictions.

Like other GLP-1 medications, Foundayo® works by mimicking the natural GLP-1 hormone. This helps:

• Regulate appetite and reduce "food noise"

• Slow the rate at which the stomach empties, helping you feel full longer

• Improve key cardiometabolic risk markers, including waist circumference, cholesterol, triglycerides, and blood pressure

To learn more about how GLP-1 medications work in general, visit our page on Medical Weight Loss.

How to Take Foundayo®

This is where Foundayo® truly stands apart. Unlike the Wegovy® pill — which must be taken first thing in the morning on an empty stomach and requires a 30-minute wait before eating or drinking — Foundayo® can be taken any time of day, with or without food, with any amount of water.

For patients who take thyroid medication or other medications that require early-morning, empty-stomach timing, this flexibility can be a significant quality-of-life improvement.

The simple rules:

• Take one tablet, once daily

• Take it at whatever time of day works best for your routine

• No food or water restrictions before or after

• Swallow the tablet whole — do not crush, chew, or dissolve it

• If you miss a dose, skip it and resume your next scheduled dose the following day

Your Titration Schedule: Starting Low, Going Slow

Just as we do with all GLP-1 medications at Phoenix NP, we never start patients at the highest dose. A gradual titration approach is the safest and most comfortable way to find the dose that works best for your body. The FDA-approved dosing schedule for Foundayo® is as follows:

Step	Dose	Minimum Duration
Starting Dose	0.8 mg	30 days
Step 2	2.5 mg	30 days
Step 3	5.5 mg	30 days
Step 4	9 mg	30 days
Step 5	14.5 mg	30 days
Maximum Dose	17.2 mg	Ongoing

An important reminder: You do not need to reach the maximum dose to see meaningful results. At Phoenix NP, we monitor your progress closely and will discuss whether a dose increase is truly right for you at each step — never increasing "just because." Moving up too quickly can increase side effects and costs without any added clinical benefit. Your comfort and long-term success always come first.

How Effective Is Foundayo®? The Clinical Data

Foundayo® was approved based on Eli Lilly's Phase 3 ATTAIN clinical trials, which enrolled more than 4,500 adults with obesity or overweight with weight-related conditions.

Here is what the data showed:

• At the highest dose, participants lost an average of 12.4% of their body weight (approximately 27 lbs) over 72 weeks, compared to just 0.9% for those on placebo.

• Across all trial participants (regardless of dose completion), the average weight loss was approximately 11.1% of body weight vs. 2.1% for placebo — a difference of about 25 lbs on average.

• Participants also saw significant improvements in cardiovascular risk markers across all doses, including reductions in waist circumference, triglycerides, non-HDL cholesterol, and systolic blood pressure.

How does this compare to other medications?

It is important to note that there have been no head-to-head clinical trials comparing Foundayo® directly to any other weight loss medication, so direct comparisons should be interpreted carefully. In separate clinical trials (not head-to-head):

• The Wegovy® pill (oral semaglutide) produced average weight loss of ~16% at the highest dose at 64 weeks.

• The Wegovy® injection produced average weight loss of ~14.9% at 68 weeks.

• Zepbound® (tirzepatide injection) produced average weight loss of approximately 21% at 72 weeks.

Experts note that in real-world use, ease of administration and adherence can significantly influence outcomes. Because Foundayo® has no food or timing restrictions and does not need to be refrigerated unlike the injectable GLP-1s, some patients may find it easier to take consistently, which can translate to real-world effectiveness. The best medication is always the one you can take safely and consistently.

A Note for Our Female Patients: Oral Contraceptive Interaction

At Phoenix NP, we specialize in women's health and medically supervised weight loss, so we want to make sure you are aware of an important drug interaction specific to Foundayo® that is listed in the official prescribing information:

If you take oral birth control pills, Foundayo® may reduce their effectiveness. This is related to how GLP-1 medications affect the rate at which the stomach processes and absorbs other oral medications.

What this means for you:

• Talk to your Phoenix NP provider before starting Foundayo® if you use oral contraceptives.

• Your provider may recommend using an additional or alternative form of birth control for 30 days after starting Foundayo® and for 30 days after each dose increase.

• Non-oral options (such as an IUD, patch, ring, or barrier methods) are not affected by this interaction.

This is one of the many reasons why having a knowledgeable, consistent provider — one who knows your full health picture — matters so much. At Phoenix NP, your provider will review all of your medications at your intake consultation to make sure Foundayo® is safe and appropriate for you.

Side Effects and Safety

The most commonly reported side effects of Foundayo® are similar to those seen with other GLP-1 medications and are primarily gastrointestinal, especially when first starting or after a dose increase:

Common side effects: Nausea, constipation, diarrhea, vomiting, indigestion, stomach (abdominal) pain, headache, swollen belly, fatigue, belching, heartburn, gas, and hair loss.

These effects are usually temporary and most pronounced in the early weeks of treatment. Our team provides personalized nutritional guidance and lifestyle coaching to help you manage and minimize these symptoms.

Important Safety Information and Contraindications:

Foundayo® carries a Boxed Warning for thyroid C-cell tumors and should not be used in patients with:

• A personal or family history of Medullary Thyroid Carcinoma (MTC)

• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Foundayo® may also affect the absorption of other oral medications taken around the same time. Always discuss your full medication list with your provider.

For the complete prescribing information, including the full Boxed Warning, please refer to the official FDA approval documentation or the official Foundayo® prescribing information from Eli Lilly.

Who Is a Candidate?

Foundayo® is FDA-approved for adults who meet the following criteria:

• BMI of 30 or greater (obesity), OR

• BMI of 27 or greater with at least one weight-related health condition (such as high blood pressure, high cholesterol, or type 2 diabetes)

Used alongside a reduced-calorie diet and increased physical activity, it is indicated for long-term weight reduction and maintenance.

At Phoenix NP, we conduct a thorough intake review to ensure any GLP-1 medication — including Foundayo® — is clinically appropriate and safe for you personally. Your provider will review your full medical history, current medications, and health goals before prescribing.

Pricing: Understanding Your Investment

At Phoenix NP, price transparency is a core part of who we are. Here is the current pricing landscape for Foundayo® as of April 2026:

With Commercial Insurance: Eli Lilly has launched a Foundayo® Savings Card for eligible patients with commercial insurance, which may bring costs down to as little as $25 per month. Coverage and eligibility will vary by insurance plan, and many plans may still be updating their formularies. We recommend calling your insurance provider to ask whether orforglipron or Foundayo® for weight management is covered under your specific policy. Phoenix NP does not work with any insurance providers at this time.

Medicare: Starting in July 2026, Foundayo® is expected to be available for approximately $50 per month for eligible individuals on Medicare Part D.

Self-Pay / Direct Pay: For patients without insurance that covers GLP-1s, or those who prefer the simplicity of bypassing prior authorization delays, Eli Lilly has made Foundayo® available directly through LillyDirect®:

• Starting doses: As low as $149 per month for eligible self-pay patients

• Higher maintenance doses: Up to approximately $299 per month (when you refill within 45 days, otherwise the price increases to $349)

Phoenix NP regularly works with Lilly Direct to send prescriptions for Zepbound® for our current patients, and we are ready to do the same for Foundayo®. Because our practice runs entirely through telehealth, the process is streamlined — from your first consultation to your first delivery, everything can be handled quickly and conveniently from your Arizona home.

Foundayo® vs. Wegovy® Pill: Which Oral Option Is Right for You?

Now that there are two FDA-approved oral GLP-1 options, the natural question is: which one is the better fit? Here is a side-by-side look at the key differences to help frame the conversation with your provider:

	Foundayo® (Orforglipron)	Wegovy® Pill (Oral Semaglutide)
Manufacturer	Eli Lilly	Novo Nordisk
Active Ingredient Type	Small molecule (non-peptide)	Peptide
Timing	Any time of day	Must be taken first thing in the morning
Food/Water Restrictions	None	30-min wait before eating or drinking
Oral Contraceptive Interaction	Yes — discuss with provider	Less pronounced concern
Max Clinical Weight Loss	~12.4% (at highest dose, 72 wks)	~16% (at highest dose, 64 wks)
Self-Pay Starting Price	~$149/month	~$149/month
Available via Manufacturer Direct	Yes (LillyDirect)	Yes (NovoCare)

Remember: these medications have not been tested head-to-head, so choosing between them is best done in conversation with a knowledgeable provider who understands your full health picture, daily routine, and goals. That is exactly what we offer at Phoenix NP.

How to Get Started at Phoenix NP

If you are an Arizona resident interested in learning whether Foundayo® — or any other FDA-approved GLP-1 medication — is right for you, here is how our process works:

1. Free Introduction Call (Optional): Book a free, no-obligation telehealth call — phone or video — to ask questions and see if you are a candidate. No pressure, no commitment.

2. Sign Up for Care: Enroll through our Plans & Pricing page or during your intro call.

3. New Patient Intake & Consultation: We'll set up your secure patient portal, collect your health history electronically, and conduct your official initial consultation with our licensed provider to review your goals and prescribe your medication.

4. Home Delivery: We send your prescription to Lilly Direct (for Foundayo® or Zepbound®) or NovoCare (for Wegovy®), who will ship authentic, FDA-approved medication directly to your Arizona home.

5. Ongoing Support: Message your provider, schedule follow-ups, and access nutritional and lifestyle guidance — all included in your monthly subscription.

Everything from consultation to prescription to delivery is handled through telehealth. You can typically have your prescription sent within 1–2 days of your decision to move forward.

Conclusion

Foundayo® represents a meaningful new option in the medically supervised weight loss space — particularly for patients who want the proven benefits of a GLP-1 medication without the restrictions that have come with other oral formulations. The freedom to take it at any time of day, without worrying about an empty stomach or a 30-minute waiting window, makes it a genuinely more flexible choice for busy lives. If you would like to read the News Release from Eli Lilly regarding Foundayo, visit this link.

As always, the goal at Phoenix NP is not to prescribe the most talked-about medication — it is to help you find the right medication, at the right dose, with the right support for your unique body and lifestyle. At Phoenix NP, you'll see the same provider each month that will get to know you, your background, and what works for you best, rather than national telehealth chains that rotates providers on you. To get to know more about our owner and provider, Jenny, visit our About the Owner/Clinic page.

If you are ready to explore whether Foundayo® or another FDA-approved weight loss option is your next step, schedule your free introduction call today or visit our Plans & Pricing page to get started.

Disclaimer: This blog is for informational purposes only and does not constitute medical advice. All prescribing decisions are made on an individual basis by a licensed healthcare provider following a thorough clinical consultation. Phoenix NP provides telehealth services exclusively to female Arizona residents.